Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

8.110 -0.010 (-0.12%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

66 67 Next >

US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year ↗

October 16, 2023

US stocks appear on track to start higher on Monday as traders look ahead to the earnings season to serve as upside catalyst.

Via Benzinga

BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

October 16, 2023

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Is Novavax Stock a Buy Now? ↗

October 16, 2023

Is this company just a pandemic stock?

Via The Motley Fool

Novavax (NVAX) Stock Slides Despite Vaccine Availability ↗

October 13, 2023

Although Novavax’s non-mRNA vaccine being available broadly represents good news, NVAX stock suffered due to unfavorable timing.

Via InvestorPlace

The Fall Vaccination Season Is Here. Is Novavax a Buy? ↗

October 12, 2023

Novavax shares have declined 28% this year.

Via The Motley Fool

Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 11, 2023

Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in...

Via Benzinga

AZZ, VOXX International And Other Big Stocks Moving Higher On Wednesday ↗

October 11, 2023

U.S. stocks traded higher Wednesday, with the Dow Jones gaining around 100 points. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments? ↗

October 11, 2023

Vaccine revenue may have slipped but could still represent billions of dollars for these companies.

Via The Motley Fool

Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand ↗

October 09, 2023

Last week, Novavax Inc (NASDAQ: NVAX) received FDA authorization for its updated COVID-19 vaccine, targeting the omicron subvariant XBB.1.5 in

Via Benzinga

3 Pharma Stocks to Dump Before the Damage Is Done ↗

October 08, 2023

There's never a shortage of pharma stocks to sell due to the nature of the sector, especially when compounded by current fears.

Via InvestorPlace

This Could be Novavax's Big Opportunity ↗

October 07, 2023

Novavax has lagged behind bigger rivals in the vaccine market.

Via The Motley Fool

Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market? ↗

October 06, 2023

Moderna, Pfizer, and Novavax all are working on combined vaccine candidates.

Via The Motley Fool

Why Novavax Stock Fell Today ↗

October 04, 2023

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated...

Via Benzinga

Novavax's COVID-19 Shot Just In Time, Optimism Surrounds As Demand Picks Up Momentum ↗

October 04, 2023

Tuesday, the FDA granted an emergency use nod to Novavax Inc's (NASDAQ: NVAX) COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) for active immunization to prevent COVID-19 in

Via Benzinga

Why Is Tilray (TLRY) Stock Down 4% Today? ↗

October 04, 2023

Tilray has released its earnings report for its fiscal first quarter of 2024 and mixed results have TLRY stock on a wild ride today!

Via InvestorPlace

These Apple Insiders Are Selling Shares of AAPL Stock ↗

October 04, 2023

Apple stock is on the move Wednesday after several insiders at the company, including CEO Tim Cook, sold shares of AAPL.

Via InvestorPlace

Short Sellers Are Betting Against Novavax (NVAX) Stock ↗

October 04, 2023

Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap.

Via InvestorPlace

What's Going On With Moderna Stock Wednesday? ↗

October 04, 2023

Moderna, Inc (NASDAQ: MRNA) shares are trading higher Wednesday.

Via Benzinga

Trump's SPAC Partner Digital World, Novavax, Palantir, And Tesla: Why These Stocks Are Trending Today? ↗

October 03, 2023

U.S. stocks experienced a downturn, with significant losses noted toward the end of trading. The S&P 500 fell approximately 1.4%.

Via Benzinga

Topics Government Stocks

Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna ↗

October 03, 2023

The company can now join Pfizer and Moderna in launching an updated booster in the U.S.

Via Investor's Business Daily

Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On? ↗

October 03, 2023

Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S.

Via Benzinga

Why Pfizer and BioNTech Stocks Zoomed Higher Today ↗

September 29, 2023

The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle.

Via The Motley Fool

NVAX, AI, CVNA: The 3 Most Shorted Stocks This Month ↗

September 28, 2023

With the market suffering losses due to broader headwinds, hedge funds have targeted the most shorted stocks for cynical profits.

Via InvestorPlace

Topics Artificial Intelligence

Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done ↗

September 26, 2023

Investors should do their due diligence before investing in these three risky, unreliable and unprofitable biotech stocks.

Via InvestorPlace

Does This Message From Moderna Mean Bad News for Novavax? ↗

September 21, 2023

So far, Novavax has lagged behind Moderna when it comes to bringing a vaccine to market.

Via The Motley Fool

You Can Pick Up These High-Risk, High-Reward Stocks for Less Than $10 ↗

September 19, 2023

These stocks look cheap right now -- if the companies can meet their goals.

Via The Motley Fool

Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now? ↗

September 18, 2023

When it comes to Big Pharma, Japan’s Takeda Pharmaceutical Co Ltd (NYSE: TAK) is a conservative play that could prove to be a big winner given its cheap valuation and suite of new drugs that portend to...

Via Benzinga

More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone ↗

September 15, 2023

New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get...

Via Benzinga

Why COVID Vaccine Demand Might Not Be That Strong ↗

September 14, 2023

COVID hospitalizations are rising, but they're nowhere near the levels they were at a year or two ago.

Via The Motley Fool

Novavax Is a Step Behind, Again. Should You Be Worried? ↗

September 14, 2023

The FDA still is reviewing Novavax's updated vaccine candidate.

Via The Motley Fool

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

66 67 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.